accountmillion. Defibrillator Sales Defibrillator sales plunged 14 percent compared with a year earlier, when Medtronic benefitted after rival Boston Scientific Corp. pulled its products from the market for failing to seek approval from federal regulators for...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Medtronic���s Fourth-Quarter Profit Drops on Defibrillators
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account